| Literature DB >> 34788131 |
Cheng Ye1, Hiroshi Yano1,2, Creg J Workman1, Dario A A Vignali1,3,4.
Abstract
The balance between inflammatory and anti-inflammatory immune responses is maintained through immunoregulatory cell populations and immunosuppressive cytokines. Interleukin-35 (IL-35), an inhibitory cytokine that belongs to the IL-12 family, is capable of potently suppressing T cell proliferation and inducing IL-35-producing induced regulatory T cells (iTr35) to limit inflammatory responses. Over the past decade, a growing number of studies have indicated that IL-35 plays an important role in controlling immune-related disorders, including autoimmune diseases, infectious diseases, and cancer. In this review, we summarize the current knowledge about the biology of IL-35 and its contribution in different diseases, and we discuss the potential of and barriers to harnessing IL-35 as a clinical biomarker or immunotherapy.Entities:
Keywords: IL-35; autoimmune diseases; cancer; infection
Mesh:
Substances:
Year: 2021 PMID: 34788131 PMCID: PMC8820099 DOI: 10.1089/jir.2021.0147
Source DB: PubMed Journal: J Interferon Cytokine Res ISSN: 1079-9907 Impact factor: 2.607